Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.2K Sell
983
-29
-3% -$1.93K 0.02% 386
2026
Q1
$63.6K Buy
1,012
+17
+2% +$1.18K 0.02% 334
2025
Q4
$66K Buy
995
+899
+936% +$58.1K 0.02% 262
2025
Q3
$6.46K Sell
96
-15
-14% -$1.19K ﹤0.01% 988
2025
Q2
$9.69K Sell
111
-275
-71% -$21.6K ﹤0.01% 597
2025
Q1
$26.4K Buy
386
+104
+37% +$8.49K 0.01% 297
2024
Q4
$21.9K Buy
282
+273
+3,033% +$20.2K 0.01% 311
2024
Q3
$604 Hold
9
﹤0.01% 1068
2024
Q2
$1.02K Buy
9
+5
+125% +$632 ﹤0.01% 502
2024
Q1
$555 Buy
4
+2
+100% +$251 ﹤0.01% 602
2023
Q4
$249 Hold
2
﹤0.01% 646
2023
Q3
$187 Hold
2
﹤0.01% 652
2023
Q2
$258 Hold
2
﹤0.01% 613
2023
Q1
$233 Hold
2
﹤0.01% 706
2022
Q4
$226 Buy
+2
New +$220 ﹤0.01% 645

Other funds holding DXCM

True Wealth Design's DXCM Position: Q2 2026 in Review

True Wealth Design reduced its DexCom (DXCM) stake by 2.9% in Q2 2026, selling an estimated $1.93K and leaving 983 shares worth $66.2K. The position accounts for 0.02% of the portfolio, ranked #386.

True Wealth Design first reported a position in DXCM in Q4 2022 and has held it in 15 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • True Wealth Design held 983 shares of DexCom worth $66.2K as of Q2 2026.
  • True Wealth Design sold 29 DexCom shares in Q2 2026, an estimated $1.93K.
  • DexCom made up 0.02% of True Wealth Design's portfolio in Q2 2026, its #386 holding.
  • True Wealth Design first reported a position in DexCom in Q4 2022 and has held it in 15 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.